The bivalent COVID-19 vaccine given to working-aged adults afforded modest protection overall against COVID-19, while the virus strains dominant in the community were those represented in the vaccine.
http://archive.today/2022.12.21-161132/https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1